Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 19 - Issue 11 - November 2022

Insights

Interview
Interview With Nathan Fagan, MD: Using the ARTIS icono in the Interventional Pediatric Space
12/07/2022
Vascular Disease Management speaks with Interventional Radiologist Nathan Fagan, MD, from Nationwide Children’s Hospital in Columbus, Ohio, about using the ARTIS icono in the interventional pediatric space.
Vascular Disease Management speaks with Interventional Radiologist Nathan Fagan, MD, from Nationwide Children’s Hospital in Columbus, Ohio, about using the ARTIS icono in the interventional pediatric space.
Vascular Disease Management...
12/07/2022
Vascular Disease Management
Video
Best Surgery vs Less-Than-OK-Endo: Results of the BEST-CLI Trial
11/16/2022
Dr. Matthew Finn discusses the results of the just-released BEST-CLI trial.
Dr. Matthew Finn discusses the results of the just-released BEST-CLI trial.
Dr. Matthew Finn discusses the...
11/16/2022
Vascular Disease Management
Commentary
Platelet Mapping Highlights Our Burgeoning Understanding of Sex Dimorphism in Vascular Disease—and All That We Have Yet to Learn
11/16/2022
Can we delineate objective differences in responsiveness to antiplatelet medications between the sexes to explain why women with PAD have fewer risk factors yet higher rates of nonhealing and amputation?
Can we delineate objective differences in responsiveness to antiplatelet medications between the sexes to explain why women with PAD have fewer risk factors yet higher rates of nonhealing and amputation?
Can we delineate objective...
11/16/2022
Vascular Disease Management

Column

Editor's Corner
BEST-CLI: Best Surgery vs Less-Than-OK-Endo
11/16/2022
Drs. Finn and Walker discuss the results of the long-awaited BEST-CLI randomized control trial, which was presented at the American Heart Association’s 2022 Scientific Sessions in November.
Drs. Finn and Walker discuss the results of the long-awaited BEST-CLI randomized control trial, which was presented at the American Heart Association’s 2022 Scientific Sessions in November.
Drs. Finn and Walker discuss the...
11/16/2022
Vascular Disease Management

Feature

OBL Corner
The Value of Outpatient Based Labs for Endovascular Therapy of Peripheral Artery Disease: The Cardiovascular Institute of the South Experience
11/16/2022
A review of the safety, efficacy, and outcomes of lower extremity endovascular intervention in patients with symptomatic PAD.
A review of the safety, efficacy, and outcomes of lower extremity endovascular intervention in patients with symptomatic PAD.
A review of the safety,...
11/16/2022
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management

Advertisement

Advertisement

November 2022 Volume 19 Issue 11

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement